ImmunoGen Inc. (IMGN) is priced at $4.09 after the most recent trading session. At the very opening of the session, the stock price was $4.11 and reached a high price of $4.22, prior to closing the session it reached the value of $4.10. The stock touched a low price of $4.03.Recently in News on March 1, 2023, ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4). ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that on February 28, 2023, the Compensation Committee of the Company’s Board of Directors approved, in aggregate, grants of non-qualified stock option awards to purchase 49,450 shares of its common stock and restricted stock units (“RSUs”) covering 15,200 shares of its common stock to three new employees under the ImmunoGen, Inc. Inducement Equity Incentive Plan, as amended (the “Inducement Plan”). You can read further details here
ImmunoGen Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $6.63 on 08/24/22, with the lowest value was $3.10 for the same time period, recorded on 06/14/22.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
ImmunoGen Inc. (IMGN) full year performance was -17.44%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, ImmunoGen Inc. shares are logging -38.24% during the 52-week period from high price, and 32.31% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $3.10 and $6.63.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 911210 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the ImmunoGen Inc. (IMGN) recorded performance in the market was -17.44%, having the revenues showcasing -20.02% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 993.02M, as it employees total of 277 workers.
Specialists analysis on ImmunoGen Inc. (IMGN)
During the last month, 0 analysts gave the ImmunoGen Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 4.83, with a change in the price was noted -2.02. In a similar fashion, ImmunoGen Inc. posted a movement of -32.98% for the period of last 100 days, recording 3,622,484 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for IMGN is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Trends and Technical analysis: ImmunoGen Inc. (IMGN)
Raw Stochastic average of ImmunoGen Inc. in the period of last 50 days is set at 34.51%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 49.82%. In the last 20 days, the company’s Stochastic %K was 52.08% and its Stochastic %D was recorded 46.67%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -17.44%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -20.18%, alongside a downfall of -17.44% for the period of the last 12 months. The shares increased approximately by 1.11% in the 7-day charts and went up by -6.08% in the period of the last 30 days. Common stock shares were lifted by -20.02% during last recorded quarter.